BioCentury
ARTICLE | Financial News

Antisense raises EUR 8M as CEO steps aside

July 7, 2011 12:18 AM UTC

Antisense Pharma GmbH (Regensburg, Germany) raised EUR 8 million ($11.6 million) from existing investors MIG Funds and Global Asset Fund. Antisense Pharma said founder Karl-Hermann Schlingensiepen stepped aside as CEO last week; he will now be a board member and focus on the company's strategy as a consultant. Antisense said the change was based on a decision to increase the international pharmaceutical and capital market experience of the management team. Managing Director and CMO Hubert Heinrichs will be acting CEO until a successor is named. ...